Ranolazine clinical trials
Also written Ranexa.
How each study uses Ranolazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ranolazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Jan 2006 · RANEXA · NDA 021526 (FDA, Drugs@FDA)
- European Union
- 8 Jul 2008 · Ranexa (previously Latixa) · EMEA/H/C/000805 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
85 studies that test it; most in 2012 (18)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 13 |
| 2012 | 18 |
| 2013 | 9 |
| 2014 | 12 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 26 · Other 59
Gilead Sciences (18) · University of Roma La Sapienza (3) · University of Rochester (2) · University of California, San Diego (2) · Food and Drug Administration (FDA) (2) · North Florida Foundation for Research and Education (2) · Cedars-Sinai Medical Center (2) · University of Pennsylvania (2)
Often tested with
Tested in the same studies.
Verapamil (2) · Dofetilide (2) · Metformin (2) · Dronedarone (1) · Lopinavir-ritonavir drug combination (1) · Chloroquine (1) · Diltiazem (1) · Quinidine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Ranolazine.
- Mar 2027Feasibility Trial for a Right Ventricular Failure Platform TrialPhase 2 · University of Alberta
Studies
Open first, then newest update. How each study uses Ranolazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 85
- Feasibility Trial for a Right Ventricular Failure Platform TrialRecruitingPhase 2University of AlbertaNCT06570473Written as Ranolazine
- A Study of Ranolazine in ALSRecruitingPhase 2Swathy Chandrashekhar, MBBSNCT06527222Written as Ranolazine
- Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON StudyRecruitingPhase 2/3Federico II UniversityNCT07380919Written as Ranolazine
- Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese SubjectsCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT07054255Written as Test formulation (Ranolazine extended-release tablets)
- Reduce Crohn's-Associated Diarrhea With Sodium Channel TherapyTerminatedPhase 2Vanderbilt University Medical CenterNCT04456517Written as Ranolazine
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral SclerosisCompletedPhase 2University of Kansas Medical CenterNCT03472950Written as Ranolazine 500 MG
- Ranolazine in Ischemic CardiomyopathyCompletedPhase 4Midwest Cardiovascular Research FoundationNCT01345188Written as Ranexa
- Impact of Ranolazine on Coronary Microcirculatory ResistanceCompletedNot applicableUniversity of New MexicoNCT01815957Written as Rnalozine
- Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary ArteriesWithdrawnPhase 4East Carolina UniversityNCT02423265Written as Ranolazine
- Long-term Efficacy Study of Sodium Channel Blocker in LQT3 PatientsCompletedPhase 2University of RochesterNCT01648205Written as Ranolazine
- Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular DiseaseTerminatedPhase 2Novartis PharmaceuticalsNCT01562041Written as Ranolazine 500 mg
- A Pilot Trial of Ranolazine to Treat Patients With Dilated CardiomyopathyCompletedPhase 2University Medical Centre LjubljanaNCT02133911Written as Ranolazine
- Ranolazine a Potential New Therapeutic ApplicationWithdrawnPhase 4Fondazione Policlinico Universitario Agostino Gemelli IRCCSNCT02687269Written as Ranolazine
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic CardiomyopathyCompletedPhase 2IRCCS San RaffaeleNCT03953989Written as Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die
- Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial FibrillationCompletedPhase 2Gilead SciencesNCT01522651Written as Ranolazine
- Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic SyndromeCompletedPhase 4University of FloridaNCT02252406Written as Ranolazine
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)TerminatedNot applicableCardiovascular Institute of the South Clinical Research CorporationNCT01705509Written as Ranolazine
- Ranolazine Mediated PVC Reduction in Ischemic Heart DiseaseCompletedPhase 2Kent Hospital, Rhode IslandNCT02360397Written as ranolazine
- The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionCompletedNot applicableUniversity of California, San DiegoNCT01505179Written as Ranolazine
- CiPA Phase 1 ECG Biomarker Validation StudyCompletedPhase 1Food and Drug Administration (FDA)NCT03070470Written as Ranolazine
Codes
What other systems call Ranolazine · ClinicalTrials.gg INT006587
- MeSH (NLM) D000069458RanolazineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A6IEZ5M406RANOLAZINEConfirmed FDA, NLM, Wikidata
- RxNorm 35829Confirmed FDA, Wikidata
- Wikidata Q907104ranolazineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66507RanolazineOne source FDA
- DrugBank DB00243One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069458 | Ranolazine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A6IEZ5M406 | RANOLAZINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 35829 | — | Confirmed FDA, Wikidata |
| Wikidata | Q907104 | ranolazine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66507 | Ranolazine | One source FDA |
| DrugBank | DB00243 | — | One source Wikidata |
Also registered as ranolazine hydrochloride (UNII F71253DJUN).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.